Anxiety and Related Sleep Disorders - EU-27

EU-27

Revenue in the Anxiety and Related Sleep Disorders market is projected to reach US$1.49bn in 2024.
Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 0.66%, resulting in a market volume of US$1.54bn by 2029.
In global comparison, most revenue will be generated in the United States (US$3,213.00m in 2024).
In relation to total population figures, per person revenues of US$49.09 are generated in 2024.

Key regions: China, United States, Germany, India, Canada

Market

Region

Region comparison

Currency

Analyst Opinion

The Anxiety and Related Sleep Disorders market in EU-27 is experiencing significant growth due to increasing customer preferences for natural remedies and a rising awareness of mental health issues.

Customer preferences: Customers in the EU-27 region are increasingly turning to natural remedies for anxiety and sleep disorders. There is a growing preference for herbal supplements and alternative therapies such as acupuncture and aromatherapy. This shift in customer preferences can be attributed to a desire for holistic and non-pharmaceutical solutions to mental health issues. Additionally, customers are seeking products that have minimal side effects and are perceived to be safer than traditional medications.

Trends in the market: One of the key trends in the Anxiety and Related Sleep Disorders market in the EU-27 is the increasing demand for over-the-counter (OTC) medications and supplements. With the growing availability and accessibility of these products, customers are able to self-manage their anxiety and sleep disorders without the need for a prescription. This trend is driven by the convenience and affordability of OTC products, as well as the desire for greater control over one's own mental health.Another trend in the market is the rise of digital therapeutics and mobile applications for anxiety and sleep disorders. These digital solutions offer personalized treatment plans, cognitive behavioral therapy techniques, and sleep tracking functionalities. Customers are increasingly turning to these digital tools as a supplement to traditional therapies, as they provide convenience and accessibility.

Local special circumstances: In certain countries within the EU-27, there are specific cultural factors that contribute to the growth of the Anxiety and Related Sleep Disorders market. For example, in countries with a high prevalence of stress-related work environments, such as Germany, there is a greater demand for products and services that address anxiety and sleep disorders. Additionally, countries with a strong tradition of natural medicine, such as France, have a higher demand for herbal remedies and alternative therapies.

Underlying macroeconomic factors: The growth of the Anxiety and Related Sleep Disorders market in the EU-27 can also be attributed to underlying macroeconomic factors. The region has experienced a steady increase in disposable income, allowing customers to spend more on healthcare and wellness products. Additionally, the aging population in the EU-27 has contributed to the growth of the market, as older individuals are more likely to experience anxiety and sleep disorders. As a result, there is a greater demand for products and services that cater to the needs of this demographic.In conclusion, the Anxiety and Related Sleep Disorders market in the EU-27 is growing due to increasing customer preferences for natural remedies, the rising awareness of mental health issues, and the availability of OTC products and digital therapeutics. Cultural factors and underlying macroeconomic factors also contribute to the growth of the market in specific countries within the region.

Methodology

Data coverage:

Data encompasses B2C enterprises. Figures are based on companies' revenues, international institutes data, and global consumer survey data. Revenues refer to the retail value and include sales taxes.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use financial reports and third-party data. Next, we use relevant key market indicators and data from country-specific associations such as healthcare spending per capita, medical product spending per capita, and gross domestic product per capita. This data helps us to estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, S-Curve function, ARIMA time series model and exponential curve function. Data is modeled using current exchange rates.

Additional Notes:

The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. GCS data is reweighted for representativeness.